Skip to content

An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

an Observational Study for the Prevalence of Pharmacovigilance Practices Between Healthcare Providers in North African Nation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06428162
Enrollment
300
Registered
2024-05-24
Start date
2024-02-18
Completion date
2024-06-20
Last updated
2024-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse, Drug Hypersensitivity, Drug Interaction, Drug Reaction

Brief summary

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Interventions

OTHERquestionner

three sections questioner including: demographics, reported cases, unreported cases

Sponsors

Deraya University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* all health care providers are invited to share in the study * minimum experience required is one year in health carrier. * accept sharing in the study

Exclusion criteria

* health care providers who refuse to complete all data required in the survey. * fresh experience or participants who left health carrier

Design outcomes

Primary

MeasureTime frameDescription
reported adverse drug reactions3 monthscollect recent adverse drug reaction reports

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026